AACR Press Conference Highlights Combination Potential of Two Cyclacel Drugs

[at noodls] – Novel Drug Combination Active in Patients With Incurable BRCA-Deficient Cancers WASHINGTON, April 8, 2013 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel … more

View todays social media effects on CYCC

View the latest stocks trending across Twitter. Click to view dashboard

See who Cyclacel is hiring next, click here to view